sarcoidosi
granulomat
diseas
unknown
etiolog
character
immunophenotyp
although
humor
immun
respons
sarcoidosi
subject
mycobacteri
protein
detect
mycobacteri
antigen
capabl
induc
cellular
immun
respons
sarcoidosi
subject
report
use
enzymelink
immunospot
assay
assess
recognit
mycobacterium
tuberculosi
mycolyl
transferas
antigen
peripher
blood
mononuclear
cell
sarcoidosi
subject
purifi
protein
deriv
healthi
volunt
ppd
healthi
subject
reactiv
whole
protein
observ
sarcoidosi
subject
compar
subject
p
fisher
exact
test
ppd
subject
p
fisher
exact
test
monoclon
antibodi
hladr
inhibit
recognit
addit
immun
recognit
whole
protein
peptidemap
studi
identifi
four
immunogen
peptid
induc
immun
respons
individu
sarcoidosi
subject
suggest
multipl
epitop
mycobacteri
protein
may
role
sarcoidosi
immunopathogenesi
sarcoidosi
diseas
unknown
etiolog
character
patholog
noncas
granuloma
commonli
involv
lung
skin
lymph
node
eye
syndrom
similar
patholog
immunolog
featur
sarcoidosi
chronic
beryllium
diseas
hypersensit
pneumon
tuberculosi
illustr
granulomat
diseas
may
may
infecti
etiolog
studi
cell
receptor
gene
express
sarcoidosi
subject
reveal
oligoclon
collect
cell
site
granulomat
inflamm
consist
major
histocompat
complex
mhc
restrict
antigendriven
process
antigen
respons
elicit
respons
identifi
review
sarcoidosi
patholog
immunolog
epidemiolog
suggest
mycobacterium
antigen
may
import
recent
studi
humor
immun
also
impli
mycobacteria
may
import
sarcoidosi
immunopathogenesi
song
et
al
note
igg
antibodi
recombin
mycobacterium
tuberculosi
mtb
katg
sera
sarcoidosi
subject
compar
sera
control
p
dubaniewicz
report
sarcoidosi
subject
demonstr
humor
respons
mtb
heatshock
protein
compar
none
control
p
tuberculosi
subject
p
nine
stage
ii
sarcoidosi
subject
demonstr
higher
frequenc
antimtb
heatshock
protein
antibodi
compar
stage
sarcoidosi
subject
p
antigen
complex
compris
three
abundantli
secret
protein
antigen
b
c
protein
present
mycobacterium
speci
function
transfer
mycol
acid
lead
format
cord
factor
dimycol
complex
also
shown
induc
strong
cell
respons
infect
mtb
patient
infect
mtb
lepra
mtb
antigen
shown
induc
strong
cell
prolif
respons
well
gener
product
disrupt
gene
encod
three
compon
mtb
suggest
may
essenti
compon
bacteri
surviv
within
macrophag
due
patholog
immunolog
similar
sarcoidosi
tuberculosi
assess
immun
recognit
sarcoidosi
subject
healthi
volunt
subject
latent
tuberculosi
infect
studi
approv
vanderbilt
univers
institut
review
board
human
studi
inform
written
consent
obtain
studi
particip
studi
follow
criteria
use
patient
sarcoidosi
clinic
featur
consist
sarcoidosi
ie
acut
respiratori
ill
accompani
erythema
nodosum
hilar
adenopathi
arthriti
lofgren
syndrom
indol
progress
pulmonari
decompens
associ
radiograph
find
hilar
adenopathi
reticulonodular
infiltr
pulmonari
fibrosi
histopatholog
diagnosi
sarcoidosi
confirm
pathologist
ie
specimen
patient
confluent
noncas
granuloma
wellcircumscrib
within
surround
tissu
variabl
amount
peripher
lymphocyt
infiltr
known
microbi
caus
granuloma
format
exclud
histolog
stain
cultur
bacteria
fungi
acidfast
bacilli
clinic
inform
obtain
chart
review
patient
interview
healthi
ppd
neg
volunt
must
written
document
neg
ppd
test
ppd
posit
ppd
subject
written
document
ppd
statu
vanderbilt
employe
health
servic
evid
activ
diseas
time
studi
enrol
ppd
subject
latent
tuberculosi
defin
american
thorac
societycent
diseas
control
guidelin
latent
tuberculosi
use
criteria
tuberculin
skin
test
chest
radiograph
sputum
examin
acidfast
bacilli
stain
cultur
peripher
blood
mononuclear
cell
pbmc
isol
blood
drawn
tube
contain
ethylenediaminetetraacet
acid
edta
separ
ficollhypaqu
densiti
gradient
separ
amersham
bioscienc
accord
manufactur
instruct
pbmc
cryopreserv
fetal
calf
serum
dimethi
sulfoxid
dmso
store
liquid
nitrogen
time
analysi
acquir
whole
protein
colorado
state
univers
nation
institut
health
nih
contract
tb
vaccin
test
research
materi
isol
mtb
cell
cultur
perform
previous
describ
puriti
confirm
mass
spectrophotometri
twentynin
peptid
overlap
deriv
amino
acid
sequenc
mtb
genbank
access
number
tabl
peptid
synthes
solidphas
fmoc
chemistri
genscript
corpor
scotch
plain
nj
puriti
ident
confirm
mass
spectroscopi
puriti
confirm
highperform
liquid
chromatographi
elispot
assay
perform
describ
previous
briefli
prior
addit
cell
polyvinyliden
difluorideback
plate
coat
mab
mabtech
stockhlm
sweden
overnight
follow
day
pbmc
ad
directli
cellswel
media
supplement
mm
lglutamin
iuml
penicillin
streptomycin
heatinactiv
fetal
bovin
serum
fb
invitrogen
corpor
irvin
ca
antigen
whole
protein
specif
peptid
ad
individu
well
duplic
final
concentr
phytohemagluttin
pha
media
alon
serv
posit
neg
control
respect
plate
incub
h
co
wash
six
time
phosphat
buffer
salin
pb
plate
incub
h
biotinyl
mab
mabtech
addit
wash
dilut
streptavidinalkalin
phosphatas
conjug
ad
well
h
plate
wash
cell
detect
min
color
reaction
use
chromogen
alkalin
phosphatas
substrat
bcipnbt
substrat
kit
vector
laboratori
interferongamma
produc
cell
count
use
immunospot
analyz
cellular
technolog
limit
ctl
cleveland
oh
result
express
number
spotform
cell
sfc
per
pbmc
number
antigenspecif
secret
cell
calcul
subtract
neg
control
valu
establish
sfc
count
neg
control
alway
sfc
per
input
cell
posit
respons
defin
least
pbmc
least
three
time
background
assay
use
pbmc
ppd
sarcoidosi
subject
perform
simultan
technician
blind
clinic
diagnosi
studi
particip
throughout
analysi
due
limit
avail
pbmc
studi
particip
screen
peptid
immunogen
epitop
use
pbmc
sarcoidosi
ppd
healthi
volunt
immunogen
epitop
group
describ
result
present
mhc
class
ii
molecul
determin
addit
monoclon
antibodi
mab
hladr
hladp
hladq
kindli
provid
gift
dr
andrew
fontenot
univers
colorado
health
scienc
center
denver
co
concentr
h
prior
addit
pbmc
identifi
cell
respons
stain
combin
cell
surfac
marker
intracellular
stain
perform
previous
describ
briefli
pbmc
incub
mab
becton
dickinson
co
h
addit
brefeldin
sigma
follow
incub
co
cell
wash
stain
surfac
antibodi
becton
dickinson
min
wash
fixat
permeabil
use
fix
perm
kit
accord
manufactur
instruct
caltag
burlingam
ca
mab
becton
dickinson
ad
min
lymphocyt
popul
identifi
use
forward
light
scatter
pattern
fluoresc
intens
analyz
use
lsr
ii
multiparamet
cytomet
becton
dickinson
immunocytometri
system
case
inhibit
assay
elispot
analysi
pbmc
preincub
antihladr
antihladp
antihladq
mab
ugml
final
concentr
h
ad
well
elispot
assay
perform
outlin
comparison
distribut
cell
frequenc
perform
use
kruskalw
test
categor
comparison
immun
reactiv
mycobacteri
antigen
individu
within
group
analyz
use
fisher
exact
test
perform
comparison
report
pvalu
twosid
analys
perform
use
r
version
sixtythre
subject
recruit
particip
studi
sarcoidosi
subject
healthi
volunt
subject
latent
tuberculosi
infect
sarcoidosi
subject
africanamerican
male
less
year
age
control
patient
africanamerican
male
less
year
age
tabl
ii
among
ppd
subject
africanamerican
male
less
year
age
seventytwo
percent
sarcoidosi
subject
pulmonari
involv
alon
cutan
involv
alon
pulmonari
cutan
andor
central
nervou
system
involv
tabl
ii
fortyfour
percent
sarcoidosi
subject
immun
suppress
time
studi
particip
one
due
use
humera
two
due
pentoxifyllin
without
steroid
eight
due
steroid
alon
neither
control
subject
ppd
subject
immunosuppress
evid
activ
diseas
time
studi
enrol
tabl
ii
screen
analysi
peptid
identifi
distinct
pattern
recognit
among
sarcoidosi
ppd
subject
test
peptid
assess
immun
recognit
among
ppd
sarcoidosi
subject
recognit
multipl
peptid
among
ppd
subject
greatest
percentag
subject
respond
peptid
peptid
fig
among
sarcoidosi
subject
peptid
frequent
recogn
peptid
fig
recognit
four
peptid
among
healthi
volunt
test
data
shown
due
strong
respons
peptid
sarcoidosi
subject
chosen
analysi
studi
particip
pbmc
avail
tabl
ii
among
sarcoidosi
subject
demonstr
immun
reactiv
whole
protein
compar
healthi
volunt
p
fisher
exact
test
subject
p
latent
tuberculosi
infect
tabl
ii
signific
associ
sex
race
site
involv
recognit
associ
immun
recognit
presenc
immunosuppress
sarcoidosi
subject
immun
suppress
recogn
whole
protein
compar
subject
immun
suppress
p
order
determin
whether
race
affect
find
perform
multivari
logist
regress
analysi
compar
express
among
sarcoid
control
sarcoid
ppd
subject
adjust
race
result
consist
univari
analysi
sarcoid
control
differ
odd
ratio
confid
interv
ci
p
sarcoid
ppd
appear
differ
statist
signific
ci
p
locat
involv
sarcoidosi
also
alter
find
comparison
three
group
also
reveal
signific
differ
distribut
cell
frequenc
lack
reactiv
group
expect
consid
subject
healthi
volunt
neg
skin
test
likewis
observ
strong
immun
respons
protein
among
subject
latent
tuberculosi
infect
consist
prior
report
ppd
subject
demonstr
largest
percentag
subject
recogn
also
possess
greatest
median
cell
frequenc
fig
two
healthi
volunt
respond
magnitud
recognit
detect
two
subject
similar
observ
respond
sarcoidosi
ppd
subject
although
sarcoidosi
subject
possess
histolog
cultur
evid
support
infect
mycobacteria
immun
recognit
whole
protein
observ
magnitud
recognit
sarcoidosi
subject
lower
observ
ppd
subject
p
higher
observ
subject
p
fig
result
peptidemap
studi
identifi
peptid
immunogen
among
sarcoidosi
subject
fig
tabl
assess
immun
recognit
four
peptid
among
studi
particip
suffici
pbmc
avail
sarcoidosi
control
ppd
control
subject
ppd
subject
recogn
whole
protein
four
demonstr
immun
recognit
four
peptid
tabl
ii
healthi
volunt
test
nine
lack
recognit
whole
protein
four
peptid
seven
sarcoidosi
subject
recogn
peptid
seven
five
subject
recogn
two
peptid
tabl
ii
peptid
frequent
immunogen
peptid
among
sarcoidosi
subject
fig
prior
report
demonstr
import
hladr
allel
immun
recognit
mtb
lepra
antigen
flow
cytometri
reveal
immun
recognit
whole
protein
conduct
primarili
cell
could
inhibit
monoclon
antibodi
hladr
monoclon
antibodi
hladp
hladq
fig
result
flow
cytometr
analysi
repres
subject
shown
fig
use
elispot
assess
class
ii
antigen
import
present
whole
protein
among
sarcoidosi
subject
observ
partial
complet
inhibit
immun
recognit
whole
protein
monoclon
antibodi
hladr
monoclon
antibodi
hladp
hladq
littl
effect
immun
recognit
elispot
fig
previou
report
util
immun
recognit
microbi
antigen
identifi
potenti
infecti
agent
work
demonstr
immun
respons
whole
protein
peptid
pbmc
sarcoidosi
subject
sarcoidosi
immunolog
epidemiolog
patholog
suggest
mycobacteria
may
import
pathogenesi
immun
respons
whole
protein
among
subject
sarcoidosi
two
healthi
volunt
well
major
subject
latent
tuberculosi
mtb
unlik
sarcoidosi
antigen
howev
demonstr
immun
recognit
antigen
significantli
higher
frequenc
sarcoidosi
subject
compar
skin
test
neg
healthi
volunt
region
suggest
respons
repres
reactiv
environment
mycobacteria
fig
interest
recent
molecular
immunolog
studi
independ
laboratori
around
world
also
report
associ
mycobacteria
sarcoidosi
suggest
immun
recognit
secondari
environment
mycobacteria
unlik
recent
report
detect
mtb
heatshock
protein
antigen
sarcoidosi
granuloma
well
cellular
immun
respons
mycobacteri
antigen
katg
among
sarcoidosi
subject
mycobacteria
found
sarcoidosi
specimen
test
suggest
sarcoidosi
may
common
patholog
phenotyp
secondari
differ
etiolog
one
mycobacteria
detect
immun
respons
mycobacteri
antigen
provid
anoth
strong
immunolog
link
mycobacteria
sarcoidosi
immunopathogenesi
uniqu
pattern
recognit
mtb
peptid
subject
tuberculosi
leprosi
also
describ
tuberculosi
subject
report
recogn
mtb
peptid
lepromat
patient
recogn
mtb
peptid
thought
dual
recognit
mtb
observ
tuberculosi
leprosi
patient
due
close
genet
homolog
tuberculosi
lepra
uniqu
pattern
recognit
reflect
distinct
studi
ppd
subject
recogn
peptid
frequent
recogn
sarcoidosi
subject
initi
screen
recognit
peptid
occur
among
ppd
subject
much
less
frequent
peptid
fig
test
four
peptid
ppd
subject
pbmc
avail
reveal
four
recogn
peptid
among
sarcoidosi
subject
peptid
recogn
seven
sarcoidosi
subject
mani
recogn
two
peptid
tabl
ii
fig
prior
molecular
analysi
sarcoidosi
granuloma
suggest
presenc
mycobacterium
speci
ident
mtb
complex
well
speci
genet
distinct
beyond
capabl
studi
determin
exact
mycobacteri
speci
sarcoidosi
subject
respond
futur
investig
involv
molecular
immunolog
analysi
mycobacteri
protein
cohort
sarcoidosi
subject
warrant
interest
note
detect
immun
recognit
either
whole
protein
peptid
subject
vari
clinic
phenotyp
includ
pulmonari
extrapulmonari
diseas
central
nervou
system
cutan
five
six
sarcoidosi
subject
cutan
involv
recogn
well
subject
central
nervou
system
involv
tabl
ii
assess
system
respons
comment
role
mycobacteri
antigen
specif
site
sarcoidosi
involv
addit
recognit
whole
protein
immun
respons
individu
sarcoidosi
subject
multipl
peptid
detect
suggest
consist
tuberculosi
infect
sarcoidosi
subject
recogn
singl
domin
epitop
gener
immun
respons
tomultipl
epitop
multipl
epitop
mycobacteri
protein
may
associ
sarcoidosi
immunopathogenesi
demonstr
immun
recognit
sarcoidosi
pbmc
suggest
mycobacteri
antigen
may
import
sarcoidosi
immunopathogenesi
studi
purport
identifi
mycobacterium
antigen
may
import
sarcoidosi
pathogenesi
provid
immunolog
link
mycobacteria
sarcoidosi
pathogenesi
mycobacteri
antigen
may
serv
incit
stimulu
immun
system
possibl
establish
persist
infect
essenti
portion
complex
facilit
surviv
bacterium
within
host
macrophag
find
warrant
investig
role
mycobacteria
sarcoidosi
pathogenesi
identif
immunogen
peptid
among
sarcoidosi
ppd
subject
sarcoidosi
latent
tuberculosi
subject
recogn
numer
peptid
although
distinct
pattern
peptid
recognit
note
group
peptid
peptid
recogn
frequent
among
subject
latent
tuberculosi
recognit
two
peptid
among
sarcoidosi
subject
group
recogn
peptid
peptid
detect
higher
frequenc
among
sarcoidosi
subject
distribut
cell
frequenc
immun
recognit
sarcoidosi
ppd
subject
bar
repres
percentil
group
studi
particip
greatest
percentag
subject
well
highest
cell
frequenc
note
subject
latent
tuberculosi
infect
two
control
subject
recogn
whole
protein
frequenc
similar
observ
sarcoidosi
ppd
subject
despit
neg
histolog
cultur
mycobacteria
among
sarcoidosi
subject
respons
observ
close
parallel
ppd
group
epitop
map
sarcoidosi
subject
addit
immun
recognit
whole
protein
abl
assess
reactiv
four
peptid
among
sarcoidosi
subject
seven
demonstr
reactiv
one
four
peptid
peptid
frequent
recogn
peptid
five
subject
immun
recognit
two
peptid
despit
lack
reactiv
whole
protein
sarcoidosi
subject
demonstr
signific
recognit
three
four
peptid
inhibit
whole
protein
hladr
flow
cytometri
reveal
primarili
cell
respons
among
sarcoidosi
subject
whole
protein
could
inhibit
complet
antihladr
monoclon
antibodi
elispot
analysi
confirm
hladr
import
recognit
whole
protein
among
sarcoidosi
subject
wherea
hladq
hladp
appear
role
antigen
present
